Pharmacists Improve Care of Diabetics While Cutting Costs, Research Shows
ScienceDaily (Jan. 4, 2010) — The role of pharmacists hasn’t received much attention in the debate on the cost of health care. But national and regional studies show that when pharmacists directly participate in patient care, they significantly reduce treatment costs and improve outcomes.
A study on diabetic patients by the University at Buffalo School of Pharmacy and Pharmaceutical Sciences identified cost savings with improvements in a key indicator of glucose control in diabetes patients, the hemoglobin A1C measurement. The A1C provides a three-month average of the amount of excess glucose in the blood. Higher A1Cs indicate that a patient is at higher risk for developing long-term complications associated with diabetes, such as kidney disease or vision problems.
School of Pharmacy, Buffalo School of Pharmacy, University, Pharmaceutical Sciences, Pharmaceutical, pharmacists, Pharmacy, School, health care, health, care, Pharmacy Schools and University
ASCP Research and Education Foundation
Archives
- December 2011 (10)
- November 2011 (6)
- August 2011 (20)
- January 2010 (5)
- November 2009 (9)
- October 2009 (22)
- September 2009 (20)
- August 2009 (198)
- July 2009 (97)
- June 2009 (6)
- May 2009 (10)
- April 2009 (18)
- March 2009 (32)
- February 2009 (18)
- January 2009 (3)
- December 2008 (3)
- November 2008 (2)
- October 2008 (5)
- September 2008 (6)
- August 2008 (6)
- July 2008 (3)
- June 2008 (6)
- May 2008 (6)
Recent Posts
- Student Pharmacists to Receive National Community Engaged Service Award American Association of Colleges of Pharmacy (AACP)
- KLE University’s College of Pharmacy conducts National Pharmacy Week
- Culprits of Biotech’s Malaise: Let’s Also Look in the Mirror
- FDA approves first diabetes-cholesterol combo pill
- UPDATE 2-Amgen signals R&D changes to employees
- Study: Orphan drugs win favored status in FDA reviews
- Why Contract Research Organizations Are So Hot
- Lipitor – Why There Will Never Be Another Drug Like Lipitor
- Pfizer’s Lipitor: How Big Pharma Blocks Reimbursement Of Generics
- Ranbaxy’s Lipitor Generic Approved by U.S. FDA, Threatening Pfizer Sales
- School of Pharmacy Dean Presents 2011 State of the School Address
- Child care center construction to begin soon
- Brookline High School peer leadership program receives grant
- 7 Pharma colleges blacklisted
- Norton to invest in UK pharmacy program for three more years